Cart
sales@molnova.com
PRMT6-IN-3
CAS No. 2890765-10-1
PRMT6-IN-3( —— )
Catalog No. M36506 CAS No. 2890765-10-1
PRMT6-IN-3 is a selective PRMT6 inhibitor with an IC50 value of 192 nM.PRMT6-IN-3 has anticancer activity and induces apoptosis in cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 73 | Get Quote |
|
| 5MG | 107 | Get Quote |
|
| 10MG | 163 | Get Quote |
|
| 25MG | 273 | Get Quote |
|
| 50MG | 419 | Get Quote |
|
| 100MG | 573 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePRMT6-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionPRMT6-IN-3 is a selective PRMT6 inhibitor with an IC50 value of 192 nM.PRMT6-IN-3 has anticancer activity and induces apoptosis in cancer cells.
-
DescriptionPRMT6-IN-3 (compound 25) is a selective PRMT6 inhibitor with an IC50 value of 192 nM. PRMT6-IN-3 can induce apoptosis in cancer cells and has anticancer activity.
-
In VitroPRMT6-IN-3(compound 25) (80 μM, 3-7 days) has anti-proliferative activity against HCC827 and MDA-MB-435 cells. PRMT6-IN-3(compound 25) (0-40 μM, 72 h) significantly induces apoptosis of cancer cells in a dose-dependent manner. Among them, a concentration of 40 μM could induce apoptosis in 43.44% and 35.08% of HCC827 and MDA-MB-435 cells, respectively.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorHistone Methyltransferase | Apoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2890765-10-1
-
Formula Weight374.5
-
Molecular FormulaC19H26N4O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N(CCNC)C)C1=CC(=CN=C1)C2=CC=C(NS(=O)(=O)C3CC3)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Qiangsheng Zhang, et al. Design, synthesis and evaluation of antitumor activity of selective PRMT6 inhibitors. Eur J Med Chem. 2022 Dec 20;247:115032.?
molnova catalog
related products
-
HBVpol502, HBV polym...
HBVpol502, HBV polymerase (502 - 510)
-
Camelliaside B
Camelliaside B possesses deglycosylation activity.
-
(±)8(9)-EpETE
Eicosapentaenoic acid is converted to epoxyeicosatetraenoic acids (EpETEs) by several cytochrome P450 isoforms. The major product of this epoxygenase pathway, (±)17(18)-EpETE.
